- Home
- RIGL vs OBT Comparison
RIGL vs OBT Comparison
Compare RIGL & OBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RIGL | OBT |
|---|---|---|
| Founded | 1996 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 564.7M | 457.5M |
| IPO Year | 2000 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RIGL | OBT |
|---|---|---|
| Price | $32.83 | $36.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $45.67 | $36.00 |
| AVG Volume (30 Days) | ★ 279.0K | 43.9K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | ★ 1867.68 | 34.82 |
| EPS | 0.44 | ★ 0.85 |
| Revenue | ★ $294,282,000.00 | N/A |
| Revenue This Year | N/A | $14.27 |
| Revenue Next Year | $12.75 | $7.99 |
| P/E Ratio | $76.05 | ★ $42.36 |
| Revenue Growth | ★ 64.15 | N/A |
| 52 Week Low | $18.14 | $23.23 |
| 52 Week High | $52.24 | $37.99 |
Technical Indicators
Market Signals| Indicator | RIGL | OBT |
|---|---|---|
| Relative Strength Index (RSI) | 61.89 | 62.99 |
| Support Level | $28.14 | $32.82 |
| Resistance Level | $33.09 | $37.98 |
| Average True Range (ATR) | 1.40 | 1.09 |
| MACD | 0.29 | 0.18 |
| Stochastic Oscillator | 73.86 | 90.60 |
Price Performance
Historical ComparisonAbout RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.
About OBT Orange County Bancorp Inc.
Orange County Bancorp Inc is a community bank holding company providing commercial and consumer banking services to individuals, small businesses, and local governments. It operates through two segments: Banking and Wealth Management. The Banking segment, the primary revenue driver, offers loans such as commercial real estate, construction, commercial & industrial, multifamily, and residential mortgages, along with services like cash management, escrow, deposits, ATMs, and digital banking. The Wealth Management segment provides investment management, trust services (trustee, administrator, custodian), and financial planning and advisory services to individuals and institutions.